Cargando…
Transforming Growth Factor‐β and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma
Transforming growth factor (TGF)‐β suppresses early hepatocellular carcinoma (HCC) development but triggers pro‐oncogenic abilities at later stages. Recent data suggest that the receptor tyrosine kinase Axl causes a TGF‐β switch toward dedifferentiation and invasion of HCC cells. Here, we analyzed t...
Autores principales: | Haider, Christine, Hnat, Julia, Wagner, Roland, Huber, Heidemarie, Timelthaler, Gerald, Grubinger, Markus, Coulouarn, Cédric, Schreiner, Wolfgang, Schlangen, Karin, Sieghart, Wolfgang, Peck‐Radosavljevic, Markus, Mikulits, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590451/ https://www.ncbi.nlm.nih.gov/pubmed/30014484 http://dx.doi.org/10.1002/hep.30166 |
Ejemplares similares
-
Neuropilin-2 induced by transforming growth factor-β augments migration of hepatocellular carcinoma cells
por: Wittmann, Philipp, et al.
Publicado: (2015) -
Cancer and liver cirrhosis: implications on prognosis and management
por: Pinter, Matthias, et al.
Publicado: (2016) -
PRAME Is a Novel Target of Tumor-Intrinsic Gas6/Axl Activation and Promotes Cancer Cell Invasion in Hepatocellular Carcinoma
por: Hedrich, Viola, et al.
Publicado: (2023) -
Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma
por: Breitenecker, Kristina, et al.
Publicado: (2023) -
Dynamics of Axl Receptor Shedding in Hepatocellular Carcinoma and Its Implication for Theranostics
por: Holstein, Elisa, et al.
Publicado: (2018)